Securities fraud litigation history and active cases
In Litigation
0
Settlement
1
Closed
0
Total Settlement
$13.73M
3:21cv5190 • March 17, 2021
Class Period Start
March 27, 2020
Class Period End
June 28, 2022
PSLRA Deadline
May 17, 2021
Case Allegations
10b5
Statutes of Repose
Mar 27, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
September 21, 2026
Settlement Fund
$13,730,000
Settlement Status
Preliminarily Approved
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of CytoDyn Inc. between March 27, 2020 and March 30, 2022.
Claim Administrator
Strategic Claims Services
P.O. Box 230
600 N. Jackson Street, Suite 205
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://cytodynsecuritiessettlement.com/Hearing Date
November 2, 2026
Opt-out Deadline
October 12, 2026
Settlement Note
Download hereProof Of Claim
Download here
Jun 18, 2026
Preliminary Approval of Settlement
Jun 18, 2026
Notice of Pendency
Jun 18, 2026
Proof of Claim Form
Mar 18, 2026
Motion for Preliminary Approval of Settlement
Jun 25, 2025
Motion to Dismiss Denied
Jan 31, 2023
Motion to Dismiss
Jun 24, 2022
Second Amended Complaint
Feb 25, 2022
Motion to Dismiss
Dec 21, 2021
First Amended Complaint
Aug 19, 2021
Appointment of Lead Plaintiff
Apr 9, 2021
Additional Complaint
Mar 17, 2021
First Filed Complaint
TOP
